COVID-19 & CancerFreeGuest Editorial NCTN group chairs: Cancer trials take backseat to clinical care amid COVID-19 pandemic April 10, 2020Vol.46 No.15By Charles D. Blanke, Douglas S. Hawkins, Monica M. Bertagnolli, Peter J. O'Dwyer, Mitchell D. Schnall, Walter J. Curran, Norman Wolmark, Robert S. Mannel and Janet Dancey
Conversation with The Cancer LetterCOVID-19 & CancerFree COVID-19 lesson from Spain: Like the U.S., we failed to take this seriously before it came to us—we have to learn April 09, 2020Vol.46 No.15By Matthew Bin Han Ong
Conversation with The Cancer LetterCOVID-19 & CancerFree Libutti: Rutgers studies COVID-19 while bracing for its surge April 06, 2020Vol.46 No.15By Paul Goldberg
COVID-19 & CancerFreeTrials & Tribulations COVID-19 and cancer: Ethical dilemmas in immune checkpoint blockade April 03, 2020Vol.46 No.14By Allison Betof Warner
Conversation with The Cancer LetterCOVID-19 & CancerFree As Italy’s COVID-19 incidence curve flattens, Curigliano sees lessons for the U.S. April 03, 2020Vol.46 No.14By Alexandria Carolan
Conversation with The Cancer LetterFree A COVID-19 update from New York: “The only thing I hear at night now is the wail of ambulances” April 03, 2020Vol.46 No.14By Matthew Bin Han Ong
FreeGuest Editorial What cancer immunologists are doing about COVID-19 April 03, 2020Vol.46 No.14By Rachel Humphrey
COVID-19 & CancerFreeGuest Editorial Friending viral foes: The Zika story and (perhaps) lessons for COVID-19 April 03, 2020Vol.46 No.14By Scott M. Lippman
COVID-19 & CancerFreeTrials & Tribulations Against all oddsUnrelated stem cell transplants in coronavirus times March 27, 2020Vol.46 No.13By Steven Devine and Alexander Schmidt
